Clinical Trial Update: Study to Evaluate Safety, Tolerability and Efficacy of Oral E-B-FAHF-2 in Mild-to-Moderate Crohn's Disease [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial update for oral E-B-FAHF-2 evaluating safety, tolerability, and efficacy in mild-to-moderate Crohn's disease; the study is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• E-B-FAHF-2

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Crohn's Disease | Phase 1 | Status: ACTIVE_NOT_RECRUITING